A Future-Oriented Factory With High Efficiency
Mah Sing's first glove manufacturing factory successfully completed
the testing and commissioning of its first two glove production lines,
and is expected to start operation in May 2021. The first shipment of
gloves is also expected to be delivered in May and June 2021. Four more
production line are on track to be operational on 2Q2021, followed by
another six production lines in 3Q2021. Under Mah Sing's Phase 1 glove
manufacturing business, these 12 units of new, high speed glove dipping
machines - producing at a speed of 38,000 pieces of gloves per
production line per hour will have a maximum production capacity of up
to 3.68 billion pieces per annum.
Starting from scratch allows Mah Sing to put best practices in place
from the get-go, giving the Group an advantage over its peers. This is
where the glove manufacturing factory's strength lies as its production
lines are all automated for higher efficiency. An Enterprise Resource
Planning (ERP) system and advanced Supervisory Control and Data
Acquisition (SCADA) system is in place to support operations. The Group
also ensures material environmental, social and governance (ESG) factors
are considered starting from the initial stage of the venture.
In the meantime, Mah Sing has recruited experienced talents from
strong glove backgrounds to assist in running the factory. The Group has
stringent compliance requirements for workers' accommodation provided
by appointed agents. This is on top of inspections of the accommodation
to ensure they comply with the Workers' Minimum Standards of Housing and
Amenities Act 1990 (Act 446).
Mah Sing's automated, high speed production lines
Beyond Borders - Overwhelming Interests From Buyers
Automated glove stripping line
The role of technology in the efficiency of the glove business
Mah Sing has obtained certifications from the US Food & Drug
Administration (FDA) for export to the US market, and is progressing
well in obtaining the Conformité Européenne (CE) Marking for the export
to the European region. This shows Mah Sing's commitment in upholding
the highest safety standards, along with the strength to expand its
presence in the international market.
In addition, the Group has secured sufficient raw materials to meet
the overwhelming orders and interest from its buyers and distributors.
The buyers are mainly serving markets such as the United States, Canada,
Middle East, Europe, United Kingdom, Japan, China, Korea, Singapore,
Russia and Latin America. Mah Sing is encouraged by the support and
confidence shown by these buyers, many of whom are prominent brands in
the healthcare industry.
If demand continues to outstrip supply, the Group will see an
addition of another 12 lines under a second phase of expansion which is
expected to increase the capacity by another 3.69 billion pieces of
gloves per annum, doubling the initial capacity. If the market condition
is favourable, Mah Sing's ultimate goal is to grow to be among the top 5
glove manufacturers in Malaysia.
"Besides having a speed advantage, we believe Mah Sing can compete
well post-pandemic in terms of cost effectiveness, productivity, and
product quality. While we currently focus on nitrile and latex
examination gloves, we will also explore the possibility of
manufacturing non-medical, industrial, specialty and other gloves." Mah
Sing's Founder and Group Managing Director, Tan Sri Dato' Sri Leong Hoy
Kum noted.
Sustained demand is expected post-pandemic as a result of more
stringent regulations and higher awareness on the importance of hygienic
practices. This is expected to generate more recurring and steady
income for Mah Sing, complementing the existing property and plastics
businesses, and contribute positively to the Group's financials going
forward. Mah Sing will also be looking at continually improving its
products through investment in Research and Development (R&D) as
developing new and innovating product is important to sustain business
growth. The Group remains committed to R&D to enhance its
competitive strength in product and material development, sustainable
technologies, engineering and automation.
If you have any proposals regarding healthcare or medical devices
related products, joint venture opportunities or interest in purchasing
gloves, you may deposit the proposals/ enquiries to us at inquiry@mshealthcare.com. You may also drop by our website at here for more information.